Esther Drill

18PUBLICATIONS
193CO-AUTHORS
Predictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursGenetic immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 04, 2026
Evaluating the Prognostic Impact of IDH Mutations in Intrahepatic Cholangiocarcinoma.

|Oct 23, 2025
Intrahepatic Cholangiocarcinoma: Recurrence Patterns, Genomics, and Survival.

Pratik Chandra, Yi Song, Esther Drill

|Aug 05, 2025
Treatment and outcomes of progression of disease post-CAR T-cell therapy in mantle cell lymphoma: a multicenter analysis.

Zachary D Epstein-Peterson, Anath C Lionel, Ashlee Joseph

|Apr 03, 2025
Maintenance therapy with romidepsin after autologous stem-cell transplant for peripheral T-cell lymphoma.

Niloufer Khan, Parastoo B Dahi, Farhad Khimani

|Dec 11, 2024
Phase II Trial of Nivolumab Plus Doxorubicin, Vinblastine, Dacarbazine as Frontline Therapy in Older Adults With Hodgkin Lymphoma.

Pallawi Torka, Tatyana Feldman, Kerry J Savage

|Nov 15, 2024
Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial.

Steven M Horwitz, Ajit J Nirmal, Jahan Rahman

Pageof 3

Frequent Collaborators

6 joint publications

Anita Kumar

6 joint publications

Andrew D Zelenetz

6 joint publications

Steven M Horwitz

6 joint publications

Santosha Vardhana